PubRank

J C Hiserodt

Author PubWeight™ 60.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med 1989 2.33
2 NKR-P1, a signal transduction molecule on natural killer cells. Science 1990 1.94
3 Characterization of the cytolytic reaction mechanism of the human natural killer (NK) lymphocyte: resolution into binding, programming, and killer cell-independent steps. J Immunol 1982 1.51
4 The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes. J Immunol 1988 1.47
5 The human LT system. I. Physical-chemical heterogeneity of LT molecules released by mitogen activated human lymphocytes in vitro. Cell Immunol 1978 1.40
6 NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium. J Immunol 1991 1.31
7 Effects of in vivo treatment with FK506 on natural killer cells in rats. Transplantation 1991 1.22
8 Generation and characterization of purified adherent lymphokine-activated killer cells in mice. J Immunol 1989 1.19
9 A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells. Cancer Res 1988 1.10
10 In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats. J Exp Med 1990 1.10
11 Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. Cancer Res 1989 1.00
12 Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells. J Exp Med 1988 0.98
13 Differential effects of various pharmacological agents on the cytolytic reaction mechanism of the human natural killer lymphocyte: further resolution of programming for lysis and KCIL into discrete stages. J Immunol 1982 0.97
14 Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am J Obstet Gynecol 1996 0.95
15 In vivo distribution and tissue localization of highly purified rat lymphokine-activated killer (LAK) cells. Cell Immunol 1988 0.94
16 Expression of surface antigens during the differentiation of human dendritic cells vs macrophages from blood monocytes in vitro. Immunobiology 1999 0.93
17 Flow-cytometric evaluation of lymphocyte subpopulations in synchronously developing Schistosoma mansoni egg and Sephadex bead pulmonary granulomas. Am J Pathol 1988 0.93
18 Expression of a laminin-like substance on the surface of murine natural killer (NK) lymphocytes and its role in NK recognition of tumor target cells. J Immunol 1985 0.93
19 Studies on the induction and expression of T cell-mediated immunity. XI. Inhibition of the "lethal hit" in T cell-mediated cytotoxicity by heterologous rat antiserum made against alloimmune cytotoxic T lymphocytes. J Immunol 1981 0.89
20 Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells. Cancer Res 1988 0.87
21 Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit. J Immunol 1983 0.87
22 In vivo migration and tissue localization of highly purified lymphokine-activated killer cells (A-LAK cells) in tumor-bearing rats. Cell Immunol 1990 0.87
23 Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion costimulation molecules ICAM-1 in human cervical cancer. Int J Radiat Oncol Biol Phys 1997 0.86
24 In vitro lymphocyte cytotoxicity. I. Evidence of multiple cytotoxic molecules secreted by mitogen activated human lymphoid cells in vitro. Cell Immunol 1976 0.86
25 Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity. Cancer Res 1988 0.85
26 Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancers. Int J Cancer 1996 0.84
27 The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures. J Exp Med 1990 0.83
28 In situ localization of 3.2.3+ natural killer cells in tissues from normal and tumor-bearing rats. Cancer Res 1991 0.83
29 Reduced natural killer cell activity in patients with systemic sclerosis. Correlation with clinical disease type. Arthritis Rheum 1988 0.83
30 NKR-P1+ cells in the rat uterus: granulated metrial gland cells are of the natural killer cell lineage. Biol Reprod 1994 0.81
31 The human LT system. V. A comparison of the relative lytic effectiveness of various MW human LT classes on 51Cr-labeled allogeneic target cells in vitro: enhanced lysis by LT complexes associated with Ig-like receptor(s). Cell Immunol 1979 0.81
32 Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor. J Immunol 1999 0.81
33 In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA). Gynecol Oncol 1997 0.81
34 Effects of splenectomy on the development of tumor-specific immunity. J Surg Res 1990 0.81
35 Identification of multiple cytolytic components associated with the beta-LT class of lymphotoxins released by mitogen-activity human lymphocytes in vitro. J Immunol 1976 0.80
36 Inhibition of human lymphocyte-mediated mitogen-induced cytotoxicity of murine L-929 cells by heterologous anti-human lymphotoxin antisera in vitro. J Immunol 1977 0.80
37 Laminin inhibits the recognition of tumor target cells by murine natural killer (NK) and natural cytotoxic (NC) lymphocytes. Am J Pathol 1985 0.80
38 Effects of retinoic acid combined with irradiation on the expression of major histocompatibility complex molecules and adhesion/costimulation molecules ICAM-1 in human cervical cancer. Gynecol Oncol 1998 0.80
39 Effects of irradiation on the expression of surface antigens in human ovarian cancer. Gynecol Oncol 1996 0.80
40 In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells. Cancer Res 1986 0.80
41 Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells. Cell Immunol 1989 0.79
42 The LT system in experimental animals. III. Physicochemical characteristics and relationships of lymphotoxin (LT) molecules released in vitro by activated lymphoid cells from several animal species. J Immunol 1979 0.79
43 Lymphocyte and monocyte-induced motility of MCF-7 cells by tumor necrosis factor-alpha. Int J Cancer 1997 0.79
44 Differential transforming growth factor-beta secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1997 0.79
45 The human lymphotoxin system. J Reticuloendothel Soc 1978 0.79
46 Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells. J Immunol 1988 0.79
47 Effect of selective depletion of natural killer cells on allograft rejection. Transplant Proc 1991 0.79
48 Inhibition of human natural killing by heterologous and monoclonal antibodies. J Immunol 1982 0.78
49 The LT system in experimental animals. I. Rapid release of high levels of lymphotoxin (LT) activity from murine lymphocytes during the interaction with lectin-treated allogeneic or xenogeneic target cells in vitro. J Immunol 1979 0.78
50 Development and characterization of an IL-4-secreting human ovarian carcinoma cell line. Gynecol Oncol 1995 0.78
51 The effects of irradiation on the expression of a tumour rejection antigen (heat shock protein gp96) in human cervical cancer. Int J Radiat Biol 1998 0.78
52 Identification of membrane-associated lymphotoxin (LT) on mitogen-activated human lymphocytes using heterologous anti-LT antisera in vitro. Cell Immunol 1977 0.78
53 Suppression of natural killer cytolytic activity in mice undergoing pulmonary granulomatous inflammation. J Immunol 1988 0.78
54 The human LT system. IV. Studies on the large MW LT complex class: association of these molecules with specific antigen binding receptor(s) in vitro. Cell Immunol 1978 0.77
55 In vitro lymphocyte cytotoxicity. II. Unstable lymphotoxins (beta-LT) secreted and inactivated by mitogen-stimulated human lymphocytes. Cell Immunol 1976 0.77
56 The LT system in experimental animals. IV. Rapid specific lysis of 51CR-labeled allogeneic target cells by highly unstable high m.w. lymphotoxin-receptor complex(es) released in vitro by activated alloimmune murine T lymphocytes. J Immunol 1979 0.77
57 Exogenously-induced, natural killer cell-mediated neuronal killing: a novel pathogenetic mechanism. J Exp Med 1992 0.77
58 The role of NK cell activity in the pathogenesis of poly I:C accelerated and spontaneous diabetes in the diabetes prone BB rat. J Autoimmun 1995 0.77
59 CD8+ T-cells are required for adoptive transfer of the BB rat diabetic syndrome. Diabetes 1993 0.77
60 The LT system in experimental animals. II. Physical and immunologic characteristics of molecules with LT activity rapidly released by murine lymphoid cells activated on lectin-coated allogeneic monolayers in vitro. J Immunol 1979 0.77
61 Studies on the mechanism of the human natural killer cell lethal hit: evidence for transfer of protease-sensitive structures requisite for target cell lysis. J Immunol 1983 0.77
62 In vivo induced allo-reactive natural killer cells. J Immunol 1992 0.77
63 The human LT system. III. Characterization of a high molecular weight LT class (complex) composed of the various smaller MW LT classes and subclasses in association with Ig-like molecules. Cell Immunol 1978 0.76
64 Effects of retinoic acid combined with interferon-gamma on the expression of major-histocompatibility-complex molecules and intercellular adhesion molecule-1 in human cervical cancer. Int J Cancer 1998 0.75
65 Differential effects of high-dose gamma irradiation on the production of transforming growth factor-beta in fresh and established human ovarian cancer. Gynecol Oncol 1996 0.75
66 Distribution of lymphocyte subsets in rat milk from normal and Trichinella spiralis-infected rats. J Reprod Immunol 1992 0.75
67 Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes. J Immunol 1982 0.75
68 Mechanisms of target cell killing by natural killer cells. Curr Opin Immunol 1989 0.75
69 Identification and partial characterization of a novel plasma membrane-associated lytic factor isolated from highly purified adherent lymphokine-activated killer cells. Cell Immunol 1992 0.75
70 Adoptive immunotherapy of murine mammary carcinoma using broadly cytotoxic cloned T lymphocytes. Prog Clin Biol Res 1987 0.75
71 The cytotoxic action of OK-432 from Streptococcus pyogenes. Med Hypotheses 1990 0.75
72 Lysis of NK target cells by soluble cytotoxic factor(s) and inhibition by a xenoantiserum directed against cytotoxic cells. Transplant Proc 1981 0.75
73 The human LT system. VII. Release of soluble forms and delivery to target L-929 cells by lectin-preactivated human lymphocytes in the absence of protein synthesis and secretory processes. Cell Immunol 1979 0.75
74 The human LT system. II. Immunological relationships of LT molecules released by mitogen activated human lymphocytes in vitro. Cell Immunol 1978 0.75
75 A unified theory for the mechanism of the lethal hit by cytotoxic T lymphocytes (CTL) and natural killer (NK) cells as defined by antisera capable of blocking the lethal hit stage of cytotoxicity. Adv Exp Med Biol 1985 0.75
76 A "nonidiotypic" inhibition of influenza-immune H-2-restricted CTL by an anti-T cell serum. J Immunol 1980 0.75
77 Lymphokine-activated killer (LAK) cell purging of leukemic bone marrow: range of activity against different hematopoietic neoplasms. Bone Marrow Transplant 1990 0.75
78 Laminin production by murine melanoma cells: possible involvement in cell motility. Clin Exp Metastasis 1987 0.75
79 T-cell membrane antigens associated with cytotoxic function. Immunol Today 1982 0.75
80 Studies on the induction and expression of T-cell-mediated immunity. XIII. Membrane-associated antigens of cytotoxic T lymphocytes involved in cytotoxicity. Cell Immunol 1983 0.75
81 Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure. J Immunol 1985 0.75
82 Development and characterization of an interleukin-2-transduced human ovarian carcinoma tumor vaccine not expressing major histocompatibility complex molecules. Am J Obstet Gynecol 1996 0.75
83 Is there evidence for transfer of materials from the killer cell to the target requisite for target cell lysis? Ann Inst Pasteur Immunol 1987 0.75
84 Natural cell-mediated immunity in the rabbit. Cell Immunol 1990 0.75
85 Lymphokine-activated killer cell purging of leukemia cells from bone marrow prior to syngeneic transplantation. Transplantation 1988 0.75
86 Generation of natural killer cells from Thy 1.1+ bone marrow precursor cells in the rat. Blood 1991 0.75
87 Laminin receptor expression on murine tumor cells: correlation with sensitivity to natural cell-mediated cytotoxicity. Int J Cancer 1989 0.75
88 The importance of splenectomy for the adoptive immunotherapy of cancer. Med Hypotheses 1989 0.75